World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00995917
Date of registration: 14/10/2009
Primary sponsor: University of California, San Francisco
Public title: A Pilot Study of Acupoint Injection for Primary Dysmenorrhea DAT
Scientific title: A Randomized, Crossover, Pilot Trial of the Feasibility and Safety of Acupoint Injection of Vitamin K for Treatment of Primary Dysmenorrhea
Date of first enrolment: October 2009
Target sample size: 18
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00995917
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Maria Chao, Dr PH, MPA
Address: 
Telephone:
Email:
Affiliation:  University of California, San Francisco
Key inclusion & exclusion criteria

Inclusion Criteria:

- Young women age 18-25

- Severe primary dysmenorrhea (defined as severe, recurrent painful periods for 6
months or more, that are not due to any other diagnosis, and that have not been
relieved, or have been only partially relieved by any other treatment)

- Nulliparous

- English speaking

- No acute or chronic conditions diagnosed or suspected

- Not on hormonal contraceptives

- Regular menstrual cycles for at least 6 months

- Has a working phone or pager

Exclusion Criteria:

- Use of hormonal contraceptives, or intra-uterine device

- Pregnancy

- Dysmenorrhea due to any other suspected or recognized causes

- History of abdominal surgery

- Participation in other concomitant therapy for acute or chronic pain

- Current treatment with anti-coagulant drugs for any reason

- Previous treatment with vitamin K acupoint injection

- Plans to be out of area during next 5 months

- Under age 18

- Known allergy to Vitamin K.



Age minimum: 18 Years
Age maximum: 25 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Dysmenorrhea
Pain, Menstrual
Intervention(s)
Other: Saline Injection
Other: Vitamin K acupoint injection
Primary Outcome(s)
self-reported pain [Time Frame: 3-5 months]
Secondary Outcome(s)
activity restriction [Time Frame: 3-5 months]
Cox retrospective symptom scale [Time Frame: 3-5 months]
medications used during menstrual cycle [Time Frame: 3-5 months]
vitamin K content in blood [Time Frame: 1-2 months]
Secondary ID(s)
A112809
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history